An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 10,040 | 7,216 | 11,537 | 8,598 | 14,014 |
| Operating Income | -10,040 | -7,216 | -11,537 | -8,598 | -14,014 |
| Other Income | 687 | 754 | 888 | 1,076 | 1,267 |
| Pre-tax Income | -9,353 | -6,462 | -10,649 | -7,522 | -12,747 |
| Net Income Continuous | -9,353 | -6,462 | -10,649 | -7,522 | -12,747 |
| Net Income | $-9,353 | $-6,462 | $-10,649 | $-7,522 | $-12,747 |
| EPS Basic Total Ops | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 |
| EPS Basic Continuous Ops | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 |
| EPS Diluted Total Ops | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 |
| EPS Diluted Continuous Ops | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 |
| EBITDA(a) | $-10,251 | $-7,515 | $-11,980 | $-9,165 | $-14,745 |